PTMCX | VFINX | PTMCX / VFINX | |
Total Expense Ratio | 1.44 | 0.14 | 1,029% |
Annual Report Gross Expense Ratio | 1.68 | 0.14 | 1,200% |
Fund Existence | 26 years | 49 years | - |
Gain YTD | 8.367 | 10.110 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 966M | 1.33T | 0% |
Annual Yield % from dividends | 0.18 | 1.09 | 16% |
Returns for 1 year | 2.33 | 16.72 | 14% |
Returns for 3 years | 28.31 | 50.29 | 56% |
Returns for 5 years | 38.65 | 91.84 | 42% |
Returns for 10 years | 31.99 | 208.47 | 15% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
KNSA | 33.38 | 0.10 | +0.30% |
Kiniksa Pharmaceuticals International plc | |||
EQH | 53.90 | -0.74 | -1.35% |
Equitable Holdings | |||
TCBX | 38.52 | -0.59 | -1.51% |
Third Coast Bancshares | |||
OTLK | 2.34 | -0.09 | -3.70% |
Outlook Therapeutics | |||
CDTG | 0.60 | -0.03 | -4.61% |
CDT Environmental Technology Investment Holdings Limited |